- News & Analysis
Page 212
Google-backed RetailMeNot to float
Google Ventures-backed digital coupon marketplace files for $230m IPO on Nasdaq.
Jun 19, 2013Cardio3 plans flotation
Investment bank Kempen is sole global coordinator for the initial public offering (IPO) after Cardio3 tried unsuccessfully to float in 2011.
Jun 8, 2013Portola raises $122m in IPO
Biogen Idec-backed Portola Pharmaceuticals raises $122m on Nasdaq.
Jun 2, 2013Tremor Video gears up for IPO
SAP and Time Warner-backed video advertising company files for IPO.
Jun 2, 2013RaQualia-backed Aratana sets IPO terms
Aratana Therapeutics, a US developer of medicines for pets, sets IPO terms.
Jun 2, 2013Epizyme raises $77m in flotation
Epizyme sold 5.1 million shares at $15 each compared to plans to offer 4.285 million shares at between $13 and $15 each.
Jun 1, 2013Epizyme to offer 4.285 million shares
Celgene owns 14.5% of Epizyme ahead of the initial public offering (IPO), after investing the portfolio company's series C round.
May 28, 2013Tableau raises $254m IPO
Stanford spin-out Tableau Software raises $254.2m in initial public offering.
May 20, 2013About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
© 2025 Mawsonia Ltd. All rights reserved.test regLogin